&nbsp;

E.1.50-CAR-TReferralWorksheet.pdf

May 2025

Drug

atezolizumab (subcut)

Other Name(s): Tecentriq® SC

Quick Link(s): Drug Monograph, Patient Info Sheet

Jul 2025

Document

Thymic-Cancer-Pathway-Map-Acknowledgments.pdf

May 2025

Document

Thymic-Diagnosis-Pathway.pdf

May 2025

Document

Thymic-Follow-Up-Pathway.pdf

May 2025

Document

Thymic-Treatment-Pathway.pdf

May 2025

Regimen

CRBPPACL+PEMB

Cancer Type:

Gynecologic,

Endometrial

Intent: Adjuvant, Curative, Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Advanced Melanoma (Unresectable or Metastatic Melanoma) and Prior Ipilimumab

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

PEMB(MNT)

Cancer Type:

Gynecologic,

Endometrial

Intent: Adjuvant, Curative, Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Primary Advanced or Recurrent Endometrial Carcinoma

Drugs Used:

pembrolizumab

... Show more tags

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

CISPPEME+PEMB

Cancer Type:

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

CRBPPEME+PEMB

Cancer Type:

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

PEMB(MNT)

Cancer Type:

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma

Drugs Used:

pembrolizumab

... Show more tags

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

AVD+NIVL

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Intent: Curative

Drugs Used:

nivolumab (Unfunded),